Literature DB >> 11194939

Cortical neurons expressing calcium binding proteins are spared in dementia with Lewy bodies.

E Gómez-Tortosa1, J L Sanders, K Newell, B T Hyman.   

Abstract

The consistent regional and laminar distribution of cortical Lewy bodies (LB) in brains of patients with dementia with Lewy bodies (DLB) suggests that only a certain subpopulation of neurons develops these alpha-synuclein-immunoreactive cytoplasmic inclusions. This study examined whether four non-overlapping neuronal subpopulations, defined by the expression of non-phosphorylated neurofilaments (SMI-32) and several calcium binding proteins (parvalbumin, calretinin and calbindin D28k), are vulnerable to LB formation. We performed peroxidase immunostaining to examine the distribution and to quantitate each neuronal subpopulation within the superior temporal sulcus (STS) area, and double-label immunohistochemistry to test for colocalization of alpha-synuclein and each neuronal marker in the STS and the entorhinal cortex. There were no significant differences between DLB brains and controls in the proportional quantity or laminar distribution of each neuronal subpopulation. Parvalbumin-immunoreactive neurons represented around 7%, calbindin D28k 8%, calretinin 10%, and SMI-32 about 20% of the total neuronal population in the STS cortex. Neurons expressing parvalbumin and SMI-32 showed a widespread distribution across layers II to VI. Neurons expressing calretinin were present in superficial layers (II to IV), and calbindin D28k-immunoreactive neurons were mostly distributed within granular layers II and IV. None of the LB observed in the STS or the entorhinal cortex were located in neurons expressing calcium binding proteins; 25% of the LB were contained in SMI-32 immunoreactive neurons. In conclusion, cortical neurons expressing calcium binding proteins are spared in DLB, while SMI-32-positive neurons are affected in proportion to their density in the cortex. However, the majority of cortical LB develop in neurons not identified by any of these markers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11194939     DOI: 10.1007/s004010000270

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  Changes induced by natural scrapie in the calretinin-immunopositive cells and fibres of the sheep cerebellar cortex.

Authors:  Adolfo Toledano; María-Isabel Alvarez; Eva Monleón; Adolfo Toledano-Díaz; Juan-José Badiola; Marta Monzón
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

Review 2.  Physiological phenotype and vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez; Paul T Schumacker
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Spatio-temporal expression analysis of the calcium-binding protein calumenin in the rodent brain.

Authors:  M Vasiljevic; F F Heisler; T J Hausrat; S Fehr; I Milenkovic; M Kneussel; W Sieghart
Journal:  Neuroscience       Date:  2011-12-06       Impact factor: 3.590

4.  Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein.

Authors:  Clare Tweedy; Nathan Kindred; Joshua Curry; Christopher Williams; John-Paul Taylor; Peter Atkinson; Fiona Randall; Daniel Erskine; Christopheer M Morris; Amy K Reeve; Gavin J Clowry; Fiona E N LeBeau
Journal:  Neurobiol Dis       Date:  2020-12-30       Impact factor: 5.996

5.  Impact of α-synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology.

Authors:  Fanfan Sun; Armando G Salinas; Severin Filser; Sonja Blumenstock; Jose Medina-Luque; Jochen Herms; Carmelo Sgobio
Journal:  Brain Pathol       Date:  2021-11-21       Impact factor: 6.508

6.  A comparative perspective on minicolumns and inhibitory GABAergic interneurons in the neocortex.

Authors:  Mary Ann Raghanti; Muhammad A Spocter; Camilla Butti; Patrick R Hof; Chet C Sherwood
Journal:  Front Neuroanat       Date:  2010-02-05       Impact factor: 3.856

7.  Differential expression of alpha-synuclein in hippocampal neurons.

Authors:  Katsutoshi Taguchi; Yoshihisa Watanabe; Atsushi Tsujimura; Harutsugu Tatebe; Seiji Miyata; Takahiko Tokuda; Toshiki Mizuno; Masaki Tanaka
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

Review 8.  Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.

Authors:  Katsutoshi Taguchi; Yoshihisa Watanabe; Atsushi Tsujimura; Masaki Tanaka
Journal:  Anat Sci Int       Date:  2018-10-25       Impact factor: 1.741

Review 9.  Initiation and propagation of α-synuclein aggregation in the nervous system.

Authors:  Baraa A Hijaz; Laura A Volpicelli-Daley
Journal:  Mol Neurodegener       Date:  2020-03-06       Impact factor: 14.195

10.  Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions.

Authors:  Lindsay E Stoyka; Andrew E Arrant; Drake R Thrasher; Dreson L Russell; Jennifer Freire; Casey L Mahoney; Ashwin Narayanan; Aseel G Dib; David G Standaert; Laura A Volpicelli-Daley
Journal:  Neurobiol Dis       Date:  2019-12-16       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.